Scientific article

Désensibilisation dans l’asthme et la rhinoconjonctivite allergiques : mise au point

Published inRevue médicale suisse, vol. 19, no. 821, p. 658-662
Publication date2023-04-05

Allergenic immunotherapy consists of repeated administration of allergenic extracts to which an individual is allergic. It is currently the only treatment that modifies the course of allergic disease and induces short- as well as long-term remission of symptoms. Two formulations are currently available: subcutaneous immunotherapy (SCIT) or sublingual immunotherapy (SLIT), with comparable efficacy. In specific situations, it can be used in combination with the new approved biologic therapies for asthma to improve tolerance of immunotherapy.

  • Humans
  • Injections, Subcutaneous
  • Desensitization, Immunologic
  • Asthma / therapy
  • Hypersensitivity / therapy
  • Sublingual Immunotherapy
  • Allergens
  • Immunotherapy
  • Rhinitis, Allergic
Citation (ISO format)
BENIADA, Camille, VANDENBERGHE-DURR, Sophie. Désensibilisation dans l’asthme et la rhinoconjonctivite allergiques : mise au point. In: Revue médicale suisse, 2023, vol. 19, n° 821, p. 658–662. doi: 10.53738/REVMED.2023.19.821.658
Main files (1)
Article (Published version)
accessLevelRestrictedaccessLevelPublic 10/06/2024
ISSN of the journal1660-9379

Technical informations

Creation10/06/2023 8:45:50 AM
First validation02/21/2024 9:24:31 AM
Update time02/21/2024 9:24:31 AM
Status update02/21/2024 9:24:31 AM
Last indexation02/21/2024 9:24:51 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack